PTHLH and myocardial infarction: Strengths of this study include the comprehensive assessment of PTHrP(1-36) (and abaloparatide) on cardiomyocyte fate in the HL-1 cell model, together with the randomized and blinded study design employed for the evaluation of myocardial infarct size in the translationally relevant swine model.